BioStem Technologies BSEM Cash Flow Statement (2024-2026)

NASDAQ BSEM
$1.47 +0.43 (+41.35%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

BioStem Technologies Quarterly Cash Flow Statement

Periods 6 quarters
Latest Jun 2026

BioStem Technologies reported cash from operations of -$5.54M and free cash flow of -$5.60M for the quarter ended Jun 2026, down 235.9% year over year. This cash flow statement covers 6 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2024 Mar2025 Jun2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income 3.91M0.01M-8.82M-8.97M
Depreciation and DepletionDep. & Depletion 0.02M0.03M0.03M0.04M
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles 0.03M0.03M0.51M0.65M
Amortization of Deferred ChargesAmort. Deferred Charges 0.02M0.04M0.05M0.05M
Depreciation & Amortization (CF)Dep. & Amort. 0.02M0.03M0.03M0.04M
Share-based CompensationStock Comp. 0.50M1.00M
Deferred Taxes -0.58M0.05M
Change in Working Capital
Change in ReceivablesChange Receivables -1.03M-7.04M3.67M-6.93M
Change in InventoryChange Inventory -0.15M0.79M-1.62M3.46M
Change in Accrued ExpensesChange Accrued Exp. -1.92M0.00M4.05M0.87M
Change in TaxesChange Taxes 1.95M-5.45M-0.03M
Change in Other Operating AssetsOther Assets Change -0.01M0.87M0.06M0.30M
Change in Other Operating LiabilitiesOther Liabilities Change -0.13M0.12M-0.05M-0.11M
Other Working Capital ChangesOther WC Changes -0.12M-0.75M-0.11M-0.41M
Cash from OperationsCash from Ops. 4.07M5.42M-0.83M-5.54M
Investing Activities
Capital ExpendituresCapex -0.16M0.66M0.00M0.06M
Change in Property, Plant and EquipmentChange in PP&E 0.16M-0.66M0.00M-0.06M
Acquisitions -15.02M30.04M
Net of Acquisitions & DivestmentsNet Acquisitions 15.02M-30.04M
Cash from Investing ActivitiesCash from Investing -0.16M-0.33M-15.02M-0.06M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment -0.10M1.12M
Net Long-Term Debt Issued (Repaid)Net LT Debt 0.10M-1.12M
Net Debt Issuances and RepaymentsNet Debt Issuance 0.10M-1.12M
Change in Capital Stock
Common Stock IssuedStock Issued 0.03M
Net Shares Issued and RepurchasedNet Shares Issued 0.03M
Net Equity Issued and RepurchasedNet Equity Issued 0.03M
Cash from Financing ActivitiesCash from Financing -0.07M-0.92M
Additional items
Change in Cash 3.84M4.17M-15.85M-6.74M
Beginning Cash Balance 0.24M22.83M22.83M22.83M29.55M29.55M
Ending Cash Balance 22.83M30.84M29.55M6.96M
Free Cash FlowFCF 4.24M4.76M-0.82M-5.60M
Net Cash FlowNCF 3.84M4.17M-15.85M-5.59M
Interest Paid 0.05M-0.03M664.002.32M

BioStem Technologies Cash Flow Statement API

Pull BioStem Technologies's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BSEM&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY